400 research outputs found
Acid sulphate soils, modelling of physical and chemical processes : report on a laboratory instaalation and In-service training mission to South-Kalimantan
Antecedents and Consequences of System Justification among Iranian Migrants in Western Europe
Antecedents and Consequences of System Justification among Iranian Migrants in Western Europe
Social decision makin
Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly
INTRODUCTION: In an animal model of acromegaly (PEPCK-hGH transgenic
mice), low systemic levels of ghrelin have been observed compared with
normal mice. We hypothesized that systemic circulating ghrelin levels are
also decreased in humans with active acromegaly and that the contribution
of central ghrelin production to systemic ghrelin levels is minimal.
OBJECTIVES: The aim of the present study was to investigate, in two
subjects with active acromegaly, whether there are differences between
systemic ghrelin levels and ghrelin concentrations in the petrosal sinus.
DESIGN: We measured systemic and central ghrelin levels in these two
acromegalic patients by bilateral simultaneous inferior petrosal sinus
sampling. Central and systemic blood samples were drawn before and 1, 5,
10, 15 and 20 min after stimulation with GH-releasing hormone (GHRH).
Ghrelin was measured with a commercially available radioimmunoassay.
RESULTS: In one acromegalic subject, the baseline systemic and central
ghrelin levels were within the same range as in two non-acromegalic obese
subjects. No gradient could be observed between central and systemic
ghrelin concentrations. Stimulation with GHRH did not change the ghrelin
concentrations in this patient. In the other acromegalic subject, the
systemic ghrelin levels were also in the same range as in two
non-acromegalic obese subjects. However, in this subject, baseline ghrelin
concentrations in the right inferior petrosal vein were considerably lower
than the systemic ghrelin concentrations, indicating a peripheral over
central gradient. Administration of GHRH induced a significant rise in
central ghrelin concentrations in the right inferior petrosal vein.
Ghrelin levels in the left inferior petrosal vein and systemic ghrelin
levels were in the normal range and GHRH stimulation did not change these
concentrations. CONCLUSIONS: The absence of a central over peripheral
ghrelin gradient in these two acromegalics indicated that circulating
ghrelin is mainly produced peripherally. Circulating systemic ghrelin
levels were not decreased in these two subjects with active acromegaly
Do high molecular weight adiponectin levels associate with radiographic progression in early rheumatiod arthritis and hand osteoarthritis?
Pathophysiology and treatment of rheumatic disease
Radiotherapy for Ledderhose disease:Results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial
Background and purpose: Radiotherapy is considered a treatment option for Ledderhose disease. However, its benefits have never been confirmed in a randomised controlled trial. Therefore, the LedRad-study was conducted. Materials and methods: The LedRad-study is a prospective multicentre randomised double-blind phase three trial. Patients were randomised to sham-radiotherapy (placebo) or radiotherapy. The primary endpoint was pain reduction at 12 months after treatment, measured with the Numeric Rating Scale (NRS). Secondary endpoints were pain reduction at 6 and 18 months after treatment, quality of life (QoL), walking abilities and toxicity.Results: A total of 84 patients were enrolled. At 12 and 18 months, patients in the radiotherapy group had a lower mean pain score compared to patients in the sham-radiotherapy group (2.5 versus 3.6 (p = 0.03) and 2.1 versus 3.4 (p = 0.008), respectively). Pain relief at 12 months was 74% in the radiotherapy group and 56% in the sham-radiotherapy group (p = 0.002). Multilevel testing for QoL scores showed higher QoL scores in the radiotherapy group compared to the sham-radiotherapy group (p < 0.001). Moreover, patients in the radiotherapy group had a higher mean walking speed and step rate with barefoot speed walking (p = 0.02). Erythema, skin dryness, burning sensations and increased pain were the most frequently reported side effects. These side effects were generally graded as mild (95%) and the majority (87%) were resolved at 18 months follow-up.Conclusion: Radiotherapy for symptomatic Ledderhose disease is an effective treatment resulting in a significant pain reduction, improvement of QoL scores and bare feet walking abilities, in comparison to sham-radiotherapy.</p
Samengestelde, peilgestuurde drainage in Nederland : voortgangsrapport 1
Verslag van het eerste uitvoeringsjaar van het project ‘Drainage tegen verdroging en voor een beter milieu; veldonderzoek naar het functioneren van samengestelde peilgestuurde drainage.’ Binnen dit project ligt de proeflocatie Ospel. In dit project willen wij hier configuraties van samengestelde, peilgestuurde drainage systemen vergelijken, en tegelijkertijd effect kwantificeren van ongedraineerd perceel op groeiomstandigheden, verloop van het gehalte aan bodemvocht en de kwaliteit van het ondiepe grondwate
OC-0052: Late toxicity in the randomized phase III Dutch Hypofractionation Trial for prostate cancer patients (HYPRO)
n/
Prediction of hemorrhagic transformation after experimental ischemic stroke using MRI-based algorithms.
Estimation of hemorrhagic transformation (HT) risk is crucial for treatment decision-making after acute ischemic stroke. We aimed to determine the accuracy of multiparametric MRI-based predictive algorithms in calculating probability of HT after stroke. Spontaneously, hypertensive rats were subjected to embolic stroke and, after 3 h treated with tissue plasminogen activator (Group I: n = 6) or vehicle (Group II: n = 7). Brain MRI measurements of T2, T2*, diffusion, perfusion, and blood-brain barrier permeability were obtained at 2, 24, and 168 h post-stroke. Generalized linear model and random forest (RF) predictive algorithms were developed to calculate the probability of HT and infarction from acute MRI data. Validation against seven-day outcome on MRI and histology revealed that highest accuracy of hemorrhage prediction was achieved with a RF-based model that included spatial brain features (Group I: area under the receiver-operating characteristic curve (AUC) = 0.85 ± 0.14; Group II: AUC = 0.89 ± 0.09), with significant improvement over perfusion- or permeability-based thresholding methods. However, overlap between predicted and actual tissue outcome was significantly lower for hemorrhage prediction models (maximum Dice's Similarity Index (DSI) = 0.20 ± 0.06) than for infarct prediction models (maximum DSI = 0.81 ± 0.06). Multiparametric MRI-based predictive algorithms enable early identification of post-ischemic tissue at risk of HT and may contribute to improved treatment decision-making after acute ischemic stroke.Multivariate analysis of psychological dat
An economic evaluation of radiotherapy for patients with symptomatic Ledderhose disease
BACKGROUND: Evidence for effectiveness of radiotherapy for Ledderhose disease was demonstrated in the LedRad-study. However, the health economic impact of Ledderhose disease is unclear. Therefore, an economic evaluation alongside the LedRad-study was planned.METHODS: The economic evaluation was performed as a cost-effectiveness and cost-utility analysis from the societal perspective. Primary outcome parameters were pain burden and Quality Adjusted Life Years (QALY), until 12 months after the end of treatment. Secondary analyses were performed with outcomes until 18 months. Incremental cost-effectiveness (ICER) and cost-utility ratios (ICUR) were calculated to express costs per unit improvement in pain burden and costs per QALY gained, for radiotherapy compared to sham-radiotherapy. Bootstrap replication was used to assess uncertainty surrounding the ratios and to construct cost-effectiveness acceptability curves for QALY gain.RESULTS: Previous analysis showed a statistically significant improvement in pain- and QoL scores in favour of radiotherapy at 12 and 18 months. At these timepoints and excluding treatment costs, cumulative total costs were considerably lower in the radiotherapy group. The ICER until 12 months after treatment was 4987 euro per unit of pain burden reduction. The ICUR was 14249 euro per QALY gained. Most of the bootstrap replications were in the upper right quadrant, indicating that health gain can be achieved at higher costs. At increasing levels of willingness to pay for a gain in QALY, the probability of cost-utility gradually increased to approximately 85%.CONCLUSIONS: In patients with symptomatic Ledderhose disease, radiotherapy, at a moderate threshold for willingness to pay, is cost-effective in terms of QoL gain.TRIAL REGISTRATION NUMBERS: NCT03507010, NL62429.042.17.</p
- …